MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    How does cognition affect reaching in Parkinson’s disease?

    J. Cosgrove, C. Picardi, S.L. Smith, S. Jamieson, J.E. Alty (Leeds, United Kingdom)

    Objective: To explore differences in kinematic parameters of reach in those with Parkinson's disease (PD) classified into normal cognition (PD-NC), mild cognitive impairment (PD-MCI) and…
  • 2016 International Congress

    Longterm outcome of cognition following subthalamic deep brain stimulation in Parkinson´s disease

    D. Gruber, C. Lisa, A. Kuehn, U. Kopp, G.H. Schneider, A. Kupsch (Beelitz-Heilstätten, Germany)

    Objective: Longterm, “real-life” assessment of cognitive evolution following subthalamic (STN) deep brain stimulation (DBS) in patients suffering from Parkinson´s disease. Background: Anecdotal reports have speculated…
  • 2016 International Congress

    Grey matter atrophy associated with the progression of cognitive decline in Parkinson’s disease (PD)

    M. Chondrogiorgi, L.G. Astrakas, A.K. Zikou, M.I. Argyropoulou, S. Konitsiotis (Ioannina, Greece)

    Objective: To investigate the pattern of grey matter (GM) atrophy associated with cognitive decline in PD by use of voxel-based morphometry (VBM) analysis. Background: Loss…
  • 2016 International Congress

    Attention and dopamine: Increased distractibility in Parkinson’s disease

    C. Warden, S. YorkWilliams, N. Ahn, D. Everling, K.L. Poston (Stanford, CA, USA)

    Objective: To determine the interactions between dopamine, Working Memory(WM) and Attentional Control(AC) in Parkinson's disease(PD) patients. Background: WM impairment is common in PD. Studies have…
  • 2016 International Congress

    Cognitive function and self-reported depressive symptoms in a population-based cohort to study non-motor-symptoms of Parkinson’s disease

    E.J. Vollstedt, K. Hückelheim, S. Tunc, J. Hampf, C. Kritzinger, M. Kasten, C. Klein (Luebeck, Germany)

    Objective: To describe the relation of depressive symptoms with cognitive performance in our cohort at baseline and two-year follow-up. Background: Cognitive function (CF) is frequent…
  • 2016 International Congress

    Impulse control disorder in Parkinson’s disease is not related to lower cognitive performance

    J. Marin-Lahoz, R. Fernandez-Bobadilla, J. Pagonabarraga, S. Martinez-Horta, B. Pascual-Sedano, J. Perez-Perez, H. Bejr-Kasem, A. Gironell, J. Kulisevsky (Barcelona, Spain)

    Objective: To compare cognitive performance in patients with and without Impulse Control Disorders (ICD) according to MDS recommendations for Parkinson's disease (PD) Mild Cognitive Impairment…
  • 2016 International Congress

    Is Apple Watch a new hope for patients with Parkinson’s disease?

    H. Ohtsubo, H. Iwaki, R. Andou, T. Tsujii, H. Babe, N. Nishikawa, M. Nagai, M. Nomoto (Tohon, Japan)

    Objective: To assess the capability of the smart watch (Apple Watch®) as a simple monitoring tool of motor fluctuation in patients with Parkinson's disease (PD).…
  • 2016 International Congress

    Overlapping corticobasal syndromes: The many faces of the Armstrong criteria

    A. Pilotto, W. Maetzler, M. Synofzik, E. Schaeffer, C. Schulte, M.A. Hobert, K. Srulijes, T. Gasser, D. Berg (Tübingen, Germany)

    Objective: To evaluate the prevalence and clinical presentation of corticobasal variants listed in the new Armstrong criteria, exploring their overlap with progressive supranuclear palsy (PSP),…
  • 2016 International Congress

    Symptom progression in a large cohort of Parkinson’s disease cases in a clinical practice setting

    K. Markopoulou, A. Premkumar, B. Schoneburg, S. Walters, R. Frigerio, M. Szela, D.M. Maraganore (Glenview, IL, USA)

    Objective: To assess the temporal profile of motor and non-motor symptoms in Parkinson's disease. Background: Parkinson's disease is characterized by varying combinations of motor and…
  • 2016 International Congress

    Multicenter report of clinical use of a non-motor symptom questionnaire for craniocervical dystonia: The DNMS quest

    L. Klingelhoefer, M. Kaiser, D. Martino, L. Perkins, M. Wienecke, A. Sauerbier, R. Untucht, D. Trivedi, K. Mammadova, T. Chiwera, A. Rizos, P. Martinez-Martin, H. Reichmann, K.R. Chaudhuri (Dresden, Germany)

    Objective: To validate a non motor symptom (NMS) questionnaire in patients with craniocervical dystonia (CCD). Background: We have reported the clinical use of a Dystonia…
  • « Previous Page
  • 1
  • …
  • 72
  • 73
  • 74
  • 75
  • 76
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley